BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17349162)

  • 21. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose methotrexate-associated acute renal failure may be an avoidable complication.
    Fong CM; Lee AC
    Pediatr Hematol Oncol; 2006; 23(1):51-7. PubMed ID: 16326413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia.
    Lau KK; Weiss AR; Jones DP
    J Oncol Pharm Pract; 2005 Mar; 11(1):31-3. PubMed ID: 16460601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic epidermal necrolysis in a girl with leukemia receiving methotrexate.
    Cakesen H; Oner AF
    Indian Pediatr; 2001 Apr; 38(4):426. PubMed ID: 11808492
    [No Abstract]   [Full Text] [Related]  

  • 25. Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.
    Huang L; Tissing WJ; de Jonge R; van Zelst BD; Pieters R
    Leukemia; 2008 Sep; 22(9):1798-800. PubMed ID: 18368069
    [No Abstract]   [Full Text] [Related]  

  • 26. Complications of tumour overkill when associated with high dose methotrexate therapy.
    Bell R; Forbes IK; Sullivan JR; Hurley TH
    Clin Exp Pharmacol Physiol Suppl; 1979; 5():47-55. PubMed ID: 400971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomic profiling reveals the mechanisms underlying the nephrotoxicity of methotrexate in children with acute lymphoblastic leukemia.
    Cheng Y; Chen Y; Zhao M; Wang M; Liu M; Zhao L
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30578. PubMed ID: 37449940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
    Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
    Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
    Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
    Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate sodium-associated UV reactivation in a patient with acute lymphoblastic leukemia.
    Yankura J; Saddic N; Jones CR; Adams DR
    Cutis; 2012 May; 89(5):233-6. PubMed ID: 22768437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral versus intravenous methotrexate: another opinion.
    Kamen BA; Winick N; Holcenberg JS
    J Clin Oncol; 1998 Jun; 16(6):2283-5. PubMed ID: 9626235
    [No Abstract]   [Full Text] [Related]  

  • 33. [Abnormally high methotrexate levels in the cerebrospinal fluid after intravenous and intrathecal treatment for acute lymphoblastic leukemia].
    Négre V; Leneveu A; Chevallier B; Roux A
    Arch Fr Pediatr; 1991 Jan; 48(1):63. PubMed ID: 2018429
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemostatic side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.
    Fisgin T; Yarali N; Kara A; Bozkurt C; Birgen D; Erten U; Duru F
    Pediatr Hematol Oncol; 2004; 21(1):77-83. PubMed ID: 14660309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré syndrome mimicking acute methotrexate-associated encephalopathy in an adolescent patient with lymphoblastic lymphoma.
    Terui K; Takahashi Y; Sasaki S; Kudo K; Kamio T; Ito E
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):615-6. PubMed ID: 20463610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia.
    Fehr T; Jacky E; Bächli EB
    Ann Hematol; 2003 Mar; 82(3):193-6. PubMed ID: 12634957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toxicity of high dose methotrexate repeated infusions in children treated for acute lymphoblastic leukemia and osteosarcoma].
    Ridolfi L; Barisone E; Vivalda M; Vivenza C; Brach Del Prever A; Leone L; Miniero R
    Minerva Pediatr; 1996 May; 48(5):193-200. PubMed ID: 8926955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interstitial nephritis developed during maintenance chemotherapy in a child with acute lymphocytic leukemia].
    Morioka Y; Imashuku S; Mizutani A; Sakata K; Yoshihara T; Ikushima S; Kawakatsu H; Todo S
    Rinsho Ketsueki; 1988 Nov; 29(11):2127-31. PubMed ID: 3236421
    [No Abstract]   [Full Text] [Related]  

  • 39. [Accidental shortening time of high dose methotrexate infusion: case report and literature review].
    Charfi R; Salouage I; Trabelsi S; Zarrouk M; Gaïes E; Jebabli N; Meddeb B; Lakhal M; Klouz A
    Ann Biol Clin (Paris); 2013; 71(2):219-22. PubMed ID: 23587592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma multiforme following prophylactic cranial irradiation and intrathecal methotrexate in a child with acute lymphoblastic leukaemia : a case report.
    Muzumdar DP; Desai K; Goel A
    Neurol India; 1999 Jun; 47(2):142-4. PubMed ID: 10402343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.